EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.566
https://www.valueinhealthjournal.com/article/S1098-3015(24)00681-8/fulltext
Section Title :
Section Order :
10044
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00681-8&doi=10.1016/j.jval.2024.03.566